nodes	percent_of_prediction	percent_of_DWPC	metapath
Norepinephrine—SLC22A3—Lamivudine—acquired immunodeficiency syndrome	0.102	0.142	CbGbCtD
Norepinephrine—SLC22A1—Indinavir—acquired immunodeficiency syndrome	0.0803	0.112	CbGbCtD
Norepinephrine—SLC22A1—Nelfinavir—acquired immunodeficiency syndrome	0.078	0.109	CbGbCtD
Norepinephrine—SLC22A2—Zidovudine—acquired immunodeficiency syndrome	0.0778	0.109	CbGbCtD
Norepinephrine—SLC22A1—Saquinavir—acquired immunodeficiency syndrome	0.0705	0.0985	CbGbCtD
Norepinephrine—SLC22A2—Lamivudine—acquired immunodeficiency syndrome	0.0602	0.0841	CbGbCtD
Norepinephrine—SLC22A1—Lamivudine—acquired immunodeficiency syndrome	0.0523	0.0731	CbGbCtD
Norepinephrine—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.0383	0.0536	CbGbCtD
Norepinephrine—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.036	0.0504	CbGbCtD
Norepinephrine—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.036	0.0504	CbGbCtD
Norepinephrine—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.0326	0.0455	CbGbCtD
Norepinephrine—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0273	0.0382	CbGbCtD
Norepinephrine—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.0247	0.0345	CbGbCtD
Norepinephrine—Lactic acidosis—Didanosine—acquired immunodeficiency syndrome	0.0139	0.0933	CcSEcCtD
Norepinephrine—Lactic acidosis—Stavudine—acquired immunodeficiency syndrome	0.0121	0.081	CcSEcCtD
Norepinephrine—Lactic acidosis—Abacavir—acquired immunodeficiency syndrome	0.0119	0.0798	CcSEcCtD
Norepinephrine—Lactic acidosis—Zidovudine—acquired immunodeficiency syndrome	0.0105	0.0704	CcSEcCtD
Norepinephrine—Lactic acidosis—Efavirenz—acquired immunodeficiency syndrome	0.00925	0.0619	CcSEcCtD
Norepinephrine—Lactic acidosis—Lamivudine—acquired immunodeficiency syndrome	0.00751	0.0503	CcSEcCtD
Norepinephrine—Retrosternal pain—Ritonavir—acquired immunodeficiency syndrome	0.00496	0.0332	CcSEcCtD
Norepinephrine—Retrosternal pain—Saquinavir—acquired immunodeficiency syndrome	0.00477	0.0319	CcSEcCtD
Norepinephrine—Blood pressure increased—Nevirapine—acquired immunodeficiency syndrome	0.00306	0.0205	CcSEcCtD
Norepinephrine—SLC18A1—vagina—acquired immunodeficiency syndrome	0.00299	0.0422	CbGeAlD
Norepinephrine—SLC18A2—blood plasma—acquired immunodeficiency syndrome	0.00282	0.0397	CbGeAlD
Norepinephrine—SLC18A1—nervous system—acquired immunodeficiency syndrome	0.00262	0.037	CbGeAlD
Norepinephrine—Pallor—Delavirdine—acquired immunodeficiency syndrome	0.00261	0.0174	CcSEcCtD
Norepinephrine—Aggression—Efavirenz—acquired immunodeficiency syndrome	0.00257	0.0172	CcSEcCtD
Norepinephrine—SLC18A1—central nervous system—acquired immunodeficiency syndrome	0.00252	0.0356	CbGeAlD
Norepinephrine—Photophobia—Zidovudine—acquired immunodeficiency syndrome	0.00241	0.0161	CcSEcCtD
Norepinephrine—PAH—blood—acquired immunodeficiency syndrome	0.00232	0.0327	CbGeAlD
Norepinephrine—SLC6A2—nerve—acquired immunodeficiency syndrome	0.00227	0.0321	CbGeAlD
Norepinephrine—DRD2—nerve—acquired immunodeficiency syndrome	0.00207	0.0292	CbGeAlD
Norepinephrine—Photophobia—Delavirdine—acquired immunodeficiency syndrome	0.00203	0.0136	CcSEcCtD
Norepinephrine—SLC18A1—brain—acquired immunodeficiency syndrome	0.002	0.0283	CbGeAlD
Norepinephrine—SLC18A1—lymph node—acquired immunodeficiency syndrome	0.00194	0.0273	CbGeAlD
Norepinephrine—PAH—nervous system—acquired immunodeficiency syndrome	0.00188	0.0266	CbGeAlD
Norepinephrine—Photophobia—Ritonavir—acquired immunodeficiency syndrome	0.00188	0.0125	CcSEcCtD
Norepinephrine—PAH—central nervous system—acquired immunodeficiency syndrome	0.00181	0.0256	CbGeAlD
Norepinephrine—Photophobia—Lamivudine—acquired immunodeficiency syndrome	0.00172	0.0115	CcSEcCtD
Norepinephrine—Sweating—Nelfinavir—acquired immunodeficiency syndrome	0.00159	0.0106	CcSEcCtD
Norepinephrine—Sweating—Stavudine—acquired immunodeficiency syndrome	0.00159	0.0106	CcSEcCtD
Norepinephrine—PAH—brain—acquired immunodeficiency syndrome	0.00144	0.0203	CbGeAlD
Norepinephrine—Sweating—Zidovudine—acquired immunodeficiency syndrome	0.00138	0.00922	CcSEcCtD
Norepinephrine—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.00132	0.0186	CbGeAlD
Norepinephrine—Sweating—Indinavir—acquired immunodeficiency syndrome	0.00128	0.00857	CcSEcCtD
Norepinephrine—ADRA2A—blood plasma—acquired immunodeficiency syndrome	0.00122	0.0171	CbGeAlD
Norepinephrine—Sweating—Efavirenz—acquired immunodeficiency syndrome	0.00121	0.0081	CcSEcCtD
Norepinephrine—SLC22A2—digestive system—acquired immunodeficiency syndrome	0.00114	0.0161	CbGeAlD
Norepinephrine—Bradycardia—Delavirdine—acquired immunodeficiency syndrome	0.0011	0.00739	CcSEcCtD
Norepinephrine—Anxiety—Nelfinavir—acquired immunodeficiency syndrome	0.0011	0.00736	CcSEcCtD
Norepinephrine—Anxiety—Stavudine—acquired immunodeficiency syndrome	0.0011	0.00733	CcSEcCtD
Norepinephrine—SLC18A2—digestive system—acquired immunodeficiency syndrome	0.00108	0.0153	CbGeAlD
Norepinephrine—Anxiety—Abacavir—acquired immunodeficiency syndrome	0.00108	0.00722	CcSEcCtD
Norepinephrine—Sweating—Ritonavir—acquired immunodeficiency syndrome	0.00107	0.00717	CcSEcCtD
Norepinephrine—SLC18A2—blood—acquired immunodeficiency syndrome	0.00103	0.0146	CbGeAlD
Norepinephrine—Hyperhidrosis—Nelfinavir—acquired immunodeficiency syndrome	0.00102	0.00684	CcSEcCtD
Norepinephrine—Hyperhidrosis—Stavudine—acquired immunodeficiency syndrome	0.00102	0.00682	CcSEcCtD
Norepinephrine—Arrhythmia—Efavirenz—acquired immunodeficiency syndrome	0.00101	0.00677	CcSEcCtD
Norepinephrine—Sweating—Lamivudine—acquired immunodeficiency syndrome	0.000984	0.00658	CcSEcCtD
Norepinephrine—SLC18A2—vagina—acquired immunodeficiency syndrome	0.000957	0.0135	CbGeAlD
Norepinephrine—Chest pain—Zidovudine—acquired immunodeficiency syndrome	0.000956	0.0064	CcSEcCtD
Norepinephrine—Anxiety—Zidovudine—acquired immunodeficiency syndrome	0.000953	0.00637	CcSEcCtD
Norepinephrine—Dyspnoea—Nelfinavir—acquired immunodeficiency syndrome	0.000943	0.00631	CcSEcCtD
Norepinephrine—Dyspnoea—Abacavir—acquired immunodeficiency syndrome	0.000926	0.0062	CcSEcCtD
Norepinephrine—SLC18A2—lung—acquired immunodeficiency syndrome	0.000905	0.0128	CbGeAlD
Norepinephrine—Chest pain—Indinavir—acquired immunodeficiency syndrome	0.000889	0.00595	CcSEcCtD
Norepinephrine—Anxiety—Indinavir—acquired immunodeficiency syndrome	0.000886	0.00593	CcSEcCtD
Norepinephrine—Hyperhidrosis—Zidovudine—acquired immunodeficiency syndrome	0.000886	0.00593	CcSEcCtD
Norepinephrine—DRD2—retina—acquired immunodeficiency syndrome	0.000858	0.0121	CbGeAlD
Norepinephrine—Hypertension—Efavirenz—acquired immunodeficiency syndrome	0.000852	0.0057	CcSEcCtD
Norepinephrine—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000847	0.00567	CcSEcCtD
Norepinephrine—ADRA1B—nervous system—acquired immunodeficiency syndrome	0.000846	0.0119	CbGeAlD
Norepinephrine—Chest pain—Efavirenz—acquired immunodeficiency syndrome	0.00084	0.00562	CcSEcCtD
Norepinephrine—SLC18A2—nervous system—acquired immunodeficiency syndrome	0.000838	0.0118	CbGeAlD
Norepinephrine—Anxiety—Efavirenz—acquired immunodeficiency syndrome	0.000837	0.0056	CcSEcCtD
Norepinephrine—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000835	0.00558	CcSEcCtD
Norepinephrine—ADRA1D—nervous system—acquired immunodeficiency syndrome	0.000827	0.0117	CbGeAlD
Norepinephrine—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.000824	0.00551	CcSEcCtD
Norepinephrine—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.000817	0.00547	CcSEcCtD
Norepinephrine—Hypertension—Delavirdine—acquired immunodeficiency syndrome	0.000815	0.00545	CcSEcCtD
Norepinephrine—ADRA1B—central nervous system—acquired immunodeficiency syndrome	0.000814	0.0115	CbGeAlD
Norepinephrine—SLC18A2—central nervous system—acquired immunodeficiency syndrome	0.000807	0.0114	CbGeAlD
Norepinephrine—Chest pain—Delavirdine—acquired immunodeficiency syndrome	0.000804	0.00538	CcSEcCtD
Norepinephrine—Anxiety—Delavirdine—acquired immunodeficiency syndrome	0.000801	0.00536	CcSEcCtD
Norepinephrine—SLC22A5—retina—acquired immunodeficiency syndrome	0.000799	0.0113	CbGeAlD
Norepinephrine—ADRA1D—central nervous system—acquired immunodeficiency syndrome	0.000797	0.0112	CbGeAlD
Norepinephrine—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000779	0.00521	CcSEcCtD
Norepinephrine—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000773	0.00517	CcSEcCtD
Norepinephrine—SLC22A1—blood—acquired immunodeficiency syndrome	0.000769	0.0108	CbGeAlD
Norepinephrine—Headache—Didanosine—acquired immunodeficiency syndrome	0.000761	0.00509	CcSEcCtD
Norepinephrine—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.00076	0.00508	CcSEcCtD
Norepinephrine—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000754	0.00504	CcSEcCtD
Norepinephrine—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000745	0.00498	CcSEcCtD
Norepinephrine—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000744	0.00497	CcSEcCtD
Norepinephrine—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000741	0.00496	CcSEcCtD
Norepinephrine—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000726	0.00485	CcSEcCtD
Norepinephrine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000718	0.0048	CcSEcCtD
Norepinephrine—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000716	0.00479	CcSEcCtD
Norepinephrine—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000713	0.00477	CcSEcCtD
Norepinephrine—SLC22A1—vagina—acquired immunodeficiency syndrome	0.000713	0.0101	CbGeAlD
Norepinephrine—SLC22A5—skin of body—acquired immunodeficiency syndrome	0.000701	0.00989	CbGeAlD
Norepinephrine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000695	0.00465	CcSEcCtD
Norepinephrine—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000689	0.00461	CcSEcCtD
Norepinephrine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000687	0.0046	CcSEcCtD
Norepinephrine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000684	0.00458	CcSEcCtD
Norepinephrine—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000683	0.00457	CcSEcCtD
Norepinephrine—SLC22A3—vagina—acquired immunodeficiency syndrome	0.000681	0.00961	CbGeAlD
Norepinephrine—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.00068	0.00455	CcSEcCtD
Norepinephrine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000673	0.0045	CcSEcCtD
Norepinephrine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000671	0.00449	CcSEcCtD
Norepinephrine—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000663	0.00444	CcSEcCtD
Norepinephrine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000663	0.00443	CcSEcCtD
Norepinephrine—Headache—Stavudine—acquired immunodeficiency syndrome	0.000661	0.00442	CcSEcCtD
Norepinephrine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000661	0.00442	CcSEcCtD
Norepinephrine—Headache—Abacavir—acquired immunodeficiency syndrome	0.000651	0.00435	CcSEcCtD
Norepinephrine—ADRB1—lung—acquired immunodeficiency syndrome	0.000649	0.00916	CbGeAlD
Norepinephrine—ADRA1B—brain—acquired immunodeficiency syndrome	0.000647	0.00912	CbGeAlD
Norepinephrine—SLC22A3—lung—acquired immunodeficiency syndrome	0.000644	0.00909	CbGeAlD
Norepinephrine—SLC18A2—brain—acquired immunodeficiency syndrome	0.00064	0.00903	CbGeAlD
Norepinephrine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000635	0.00425	CcSEcCtD
Norepinephrine—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000633	0.00423	CcSEcCtD
Norepinephrine—ADRA1D—brain—acquired immunodeficiency syndrome	0.000632	0.00892	CbGeAlD
Norepinephrine—SLC22A1—nervous system—acquired immunodeficiency syndrome	0.000624	0.00881	CbGeAlD
Norepinephrine—ADRA1A—lymphoid tissue—acquired immunodeficiency syndrome	0.000622	0.00878	CbGeAlD
Norepinephrine—SLC18A2—lymph node—acquired immunodeficiency syndrome	0.000619	0.00873	CbGeAlD
Norepinephrine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000612	0.00409	CcSEcCtD
Norepinephrine—ADRB1—nervous system—acquired immunodeficiency syndrome	0.000601	0.00848	CbGeAlD
Norepinephrine—SLC22A1—central nervous system—acquired immunodeficiency syndrome	0.000601	0.00848	CbGeAlD
Norepinephrine—SLC22A3—nervous system—acquired immunodeficiency syndrome	0.000597	0.00842	CbGeAlD
Norepinephrine—ADRA1A—blood—acquired immunodeficiency syndrome	0.000585	0.00826	CbGeAlD
Norepinephrine—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000583	0.0039	CcSEcCtD
Norepinephrine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000583	0.0039	CcSEcCtD
Norepinephrine—ADRB1—central nervous system—acquired immunodeficiency syndrome	0.000579	0.00816	CbGeAlD
Norepinephrine—SLC22A3—central nervous system—acquired immunodeficiency syndrome	0.000574	0.0081	CbGeAlD
Norepinephrine—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000574	0.00384	CcSEcCtD
Norepinephrine—SLC22A5—digestive system—acquired immunodeficiency syndrome	0.000561	0.00791	CbGeAlD
Norepinephrine—ADRA2C—blood—acquired immunodeficiency syndrome	0.000558	0.00787	CbGeAlD
Norepinephrine—SLC6A2—lung—acquired immunodeficiency syndrome	0.000552	0.00779	CbGeAlD
Norepinephrine—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000542	0.00363	CcSEcCtD
Norepinephrine—ADRA2C—spinal cord—acquired immunodeficiency syndrome	0.000537	0.00758	CbGeAlD
Norepinephrine—SLC22A5—blood—acquired immunodeficiency syndrome	0.000534	0.00754	CbGeAlD
Norepinephrine—Headache—Indinavir—acquired immunodeficiency syndrome	0.000534	0.00357	CcSEcCtD
Norepinephrine—ADRA2C—vagina—acquired immunodeficiency syndrome	0.000517	0.0073	CbGeAlD
Norepinephrine—SLC22A5—spinal cord—acquired immunodeficiency syndrome	0.000515	0.00726	CbGeAlD
Norepinephrine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000512	0.00343	CcSEcCtD
Norepinephrine—SLC6A2—nervous system—acquired immunodeficiency syndrome	0.000511	0.00721	CbGeAlD
Norepinephrine—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000508	0.00717	CbGeAlD
Norepinephrine—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000505	0.00338	CcSEcCtD
Norepinephrine—DRD2—lung—acquired immunodeficiency syndrome	0.000503	0.0071	CbGeAlD
Norepinephrine—SLC22A5—vagina—acquired immunodeficiency syndrome	0.000495	0.00699	CbGeAlD
Norepinephrine—SLC6A2—central nervous system—acquired immunodeficiency syndrome	0.000492	0.00694	CbGeAlD
Norepinephrine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.00049	0.00328	CcSEcCtD
Norepinephrine—ADRA2C—lung—acquired immunodeficiency syndrome	0.000489	0.0069	CbGeAlD
Norepinephrine—CYP1A2—blood—acquired immunodeficiency syndrome	0.000484	0.00683	CbGeAlD
Norepinephrine—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000483	0.00323	CcSEcCtD
Norepinephrine—SLC22A1—brain—acquired immunodeficiency syndrome	0.000477	0.00673	CbGeAlD
Norepinephrine—ADRA1A—nervous system—acquired immunodeficiency syndrome	0.000475	0.00671	CbGeAlD
Norepinephrine—SLC22A5—lung—acquired immunodeficiency syndrome	0.000468	0.00661	CbGeAlD
Norepinephrine—DRD2—nervous system—acquired immunodeficiency syndrome	0.000466	0.00657	CbGeAlD
Norepinephrine—ADRB1—brain—acquired immunodeficiency syndrome	0.000459	0.00648	CbGeAlD
Norepinephrine—ADRA1A—central nervous system—acquired immunodeficiency syndrome	0.000458	0.00646	CbGeAlD
Norepinephrine—SLC22A3—brain—acquired immunodeficiency syndrome	0.000456	0.00643	CbGeAlD
Norepinephrine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000453	0.00303	CcSEcCtD
Norepinephrine—ADRA2C—nervous system—acquired immunodeficiency syndrome	0.000453	0.00639	CbGeAlD
Norepinephrine—DRD2—central nervous system—acquired immunodeficiency syndrome	0.000449	0.00633	CbGeAlD
Norepinephrine—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000447	0.00299	CcSEcCtD
Norepinephrine—ADRA2A—blood—acquired immunodeficiency syndrome	0.000445	0.00628	CbGeAlD
Norepinephrine—SLC22A3—lymph node—acquired immunodeficiency syndrome	0.000441	0.00622	CbGeAlD
Norepinephrine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000436	0.00292	CcSEcCtD
Norepinephrine—ADRA2C—central nervous system—acquired immunodeficiency syndrome	0.000436	0.00615	CbGeAlD
Norepinephrine—Headache—Saquinavir—acquired immunodeficiency syndrome	0.00043	0.00287	CcSEcCtD
Norepinephrine—ADRA2A—spinal cord—acquired immunodeficiency syndrome	0.000429	0.00605	CbGeAlD
Norepinephrine—CYP1A2—lung—acquired immunodeficiency syndrome	0.000424	0.00599	CbGeAlD
Norepinephrine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000416	0.00278	CcSEcCtD
Norepinephrine—ADRA2A—vagina—acquired immunodeficiency syndrome	0.000413	0.00582	CbGeAlD
Norepinephrine—Headache—Lamivudine—acquired immunodeficiency syndrome	0.00041	0.00274	CcSEcCtD
Norepinephrine—SLC6A2—brain—acquired immunodeficiency syndrome	0.000391	0.00551	CbGeAlD
Norepinephrine—ADRA2A—lung—acquired immunodeficiency syndrome	0.00039	0.00551	CbGeAlD
Norepinephrine—SLC6A2—lymph node—acquired immunodeficiency syndrome	0.000378	0.00533	CbGeAlD
Norepinephrine—ADRA1A—brain—acquired immunodeficiency syndrome	0.000363	0.00513	CbGeAlD
Norepinephrine—ADRA2A—nervous system—acquired immunodeficiency syndrome	0.000361	0.0051	CbGeAlD
Norepinephrine—DRD2—brain—acquired immunodeficiency syndrome	0.000356	0.00502	CbGeAlD
Norepinephrine—ADRA2A—central nervous system—acquired immunodeficiency syndrome	0.000348	0.00491	CbGeAlD
Norepinephrine—ADRA2C—brain—acquired immunodeficiency syndrome	0.000346	0.00488	CbGeAlD
Norepinephrine—ADRA2C—lymph node—acquired immunodeficiency syndrome	0.000334	0.00472	CbGeAlD
Norepinephrine—SLC22A5—brain—acquired immunodeficiency syndrome	0.000332	0.00468	CbGeAlD
Norepinephrine—SLC22A5—lymph node—acquired immunodeficiency syndrome	0.00032	0.00452	CbGeAlD
Norepinephrine—ADRA2A—brain—acquired immunodeficiency syndrome	0.000276	0.0039	CbGeAlD
Norepinephrine—ADRA2A—lymph node—acquired immunodeficiency syndrome	0.000267	0.00377	CbGeAlD
Norepinephrine—ADRA1B—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	3.84e-05	0.000603	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	3.82e-05	0.0006	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	3.82e-05	0.0006	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	3.82e-05	0.000599	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	3.78e-05	0.000594	CbGpPWpGaD
Norepinephrine—ADRA2A—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	3.78e-05	0.000593	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	3.77e-05	0.000591	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	3.76e-05	0.000591	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	3.76e-05	0.000591	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	3.75e-05	0.000589	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	3.75e-05	0.000589	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.73e-05	0.000586	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.73e-05	0.000586	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	3.73e-05	0.000586	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	3.72e-05	0.000584	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	3.72e-05	0.000584	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	3.71e-05	0.000582	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	3.69e-05	0.00058	CbGpPWpGaD
Norepinephrine—DRD2—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	3.69e-05	0.000579	CbGpPWpGaD
Norepinephrine—ADRA2A—Hemostasis—CSF2—acquired immunodeficiency syndrome	3.68e-05	0.000578	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	3.67e-05	0.000576	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	3.67e-05	0.000576	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	3.64e-05	0.000571	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	3.57e-05	0.00056	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	3.56e-05	0.000558	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	3.54e-05	0.000556	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	3.54e-05	0.000556	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	3.53e-05	0.000554	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	3.48e-05	0.000546	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	3.47e-05	0.000545	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	3.47e-05	0.000545	CbGpPWpGaD
Norepinephrine—DRD2—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	3.47e-05	0.000545	CbGpPWpGaD
Norepinephrine—DRD2—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	3.47e-05	0.000545	CbGpPWpGaD
Norepinephrine—ADRA1D—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	3.45e-05	0.000542	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	3.42e-05	0.000537	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	3.42e-05	0.000537	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	3.41e-05	0.000536	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	3.41e-05	0.000536	CbGpPWpGaD
Norepinephrine—ADRA1D—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	3.4e-05	0.000533	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	3.35e-05	0.000526	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	3.34e-05	0.000525	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	3.34e-05	0.000525	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	3.32e-05	0.000521	CbGpPWpGaD
Norepinephrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	3.31e-05	0.00052	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	3.3e-05	0.000519	CbGpPWpGaD
Norepinephrine—SLC6A2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	3.26e-05	0.000512	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	3.23e-05	0.000507	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	3.2e-05	0.000503	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	3.17e-05	0.000498	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	3.17e-05	0.000498	CbGpPWpGaD
Norepinephrine—ADRA2B—Hemostasis—ALB—acquired immunodeficiency syndrome	3.16e-05	0.000497	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	3.15e-05	0.000495	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	3.15e-05	0.000495	CbGpPWpGaD
Norepinephrine—ADRB1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	3.14e-05	0.000493	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	3.13e-05	0.000492	CbGpPWpGaD
Norepinephrine—ADRA2B—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	3.11e-05	0.000489	CbGpPWpGaD
Norepinephrine—ADRA1D—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	3.11e-05	0.000488	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	3.11e-05	0.000488	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	3.11e-05	0.000488	CbGpPWpGaD
Norepinephrine—ADRB1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	3.1e-05	0.000486	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	3.09e-05	0.000485	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	3.09e-05	0.000484	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—TAT—acquired immunodeficiency syndrome	3.08e-05	0.000484	CbGpPWpGaD
Norepinephrine—ADRB2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	3.07e-05	0.000483	CbGpPWpGaD
Norepinephrine—ADRA2B—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	3.07e-05	0.000482	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	3.04e-05	0.000477	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	3.04e-05	0.000477	CbGpPWpGaD
Norepinephrine—ADRB2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	3.03e-05	0.000475	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	3e-05	0.000471	CbGpPWpGaD
Norepinephrine—ADRA2C—Hemostasis—ALB—acquired immunodeficiency syndrome	2.96e-05	0.000464	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.91e-05	0.000457	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	2.87e-05	0.00045	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.87e-05	0.00045	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.86e-05	0.000449	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.86e-05	0.000449	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.85e-05	0.000448	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.84e-05	0.000446	CbGpPWpGaD
Norepinephrine—ADRB1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.83e-05	0.000445	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.83e-05	0.000444	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.82e-05	0.000443	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	2.82e-05	0.000443	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	2.82e-05	0.000443	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.82e-05	0.000443	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.81e-05	0.000441	CbGpPWpGaD
Norepinephrine—ADRA2B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.81e-05	0.00044	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.8e-05	0.000439	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.79e-05	0.000438	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.79e-05	0.000437	CbGpPWpGaD
Norepinephrine—ADRB2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.77e-05	0.000435	CbGpPWpGaD
Norepinephrine—ADRB3—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.76e-05	0.000433	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.75e-05	0.000432	CbGpPWpGaD
Norepinephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	2.75e-05	0.000432	CbGpPWpGaD
Norepinephrine—DRD2—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	2.67e-05	0.00042	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.64e-05	0.000415	CbGpPWpGaD
Norepinephrine—DRD2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.64e-05	0.000414	CbGpPWpGaD
Norepinephrine—SLC22A2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	2.63e-05	0.000413	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.62e-05	0.000411	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—AGPS—acquired immunodeficiency syndrome	2.62e-05	0.000411	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.61e-05	0.000409	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.6e-05	0.000409	CbGpPWpGaD
Norepinephrine—DRD2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.6e-05	0.000408	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.6e-05	0.000408	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.59e-05	0.000406	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.58e-05	0.000405	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.58e-05	0.000405	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.57e-05	0.000404	CbGpPWpGaD
Norepinephrine—ADRA2B—Hemostasis—IL2—acquired immunodeficiency syndrome	2.57e-05	0.000403	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.56e-05	0.000402	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.56e-05	0.000402	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.55e-05	0.0004	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.55e-05	0.0004	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.54e-05	0.000399	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.52e-05	0.000395	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.51e-05	0.000393	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.5e-05	0.000393	CbGpPWpGaD
Norepinephrine—SLC22A1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	2.45e-05	0.000385	CbGpPWpGaD
Norepinephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	2.44e-05	0.000383	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.43e-05	0.000382	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.43e-05	0.000382	CbGpPWpGaD
Norepinephrine—PAH—Disease—IL6—acquired immunodeficiency syndrome	2.43e-05	0.000381	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.41e-05	0.000379	CbGpPWpGaD
Norepinephrine—ADRA2A—Hemostasis—ALB—acquired immunodeficiency syndrome	2.4e-05	0.000377	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.4e-05	0.000376	CbGpPWpGaD
Norepinephrine—ADRA2C—Hemostasis—IL2—acquired immunodeficiency syndrome	2.4e-05	0.000376	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.38e-05	0.000374	CbGpPWpGaD
Norepinephrine—DRD2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.38e-05	0.000373	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.37e-05	0.000373	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.36e-05	0.000371	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.36e-05	0.000371	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.36e-05	0.00037	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.34e-05	0.000368	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.34e-05	0.000367	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.33e-05	0.000365	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.31e-05	0.000363	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.31e-05	0.000362	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.29e-05	0.00036	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.28e-05	0.000357	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.22e-05	0.000348	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.22e-05	0.000348	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.2e-05	0.000345	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.2e-05	0.000345	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.19e-05	0.000344	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.18e-05	0.000343	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.17e-05	0.00034	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.17e-05	0.00034	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.16e-05	0.000339	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.15e-05	0.000337	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.15e-05	0.000337	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.13e-05	0.000334	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.11e-05	0.000332	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.11e-05	0.000331	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.08e-05	0.000327	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.05e-05	0.000322	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.05e-05	0.000322	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.02e-05	0.000317	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.02e-05	0.000317	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.98e-05	0.000311	CbGpPWpGaD
Norepinephrine—SLC22A3—Metabolism—ALB—acquired immunodeficiency syndrome	1.96e-05	0.000308	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.96e-05	0.000308	CbGpPWpGaD
Norepinephrine—ADRA2A—Hemostasis—IL2—acquired immunodeficiency syndrome	1.95e-05	0.000306	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.93e-05	0.000303	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.91e-05	0.000299	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.86e-05	0.000292	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.86e-05	0.000292	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.85e-05	0.000291	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.82e-05	0.000286	CbGpPWpGaD
Norepinephrine—ADRA1D—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.8e-05	0.000282	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.79e-05	0.000282	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.79e-05	0.000282	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.77e-05	0.000278	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.69e-05	0.000265	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.67e-05	0.000262	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.67e-05	0.000262	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.67e-05	0.000262	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.67e-05	0.000262	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.66e-05	0.000261	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.65e-05	0.000259	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.65e-05	0.000258	CbGpPWpGaD
Norepinephrine—ADRB1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.64e-05	0.000257	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.63e-05	0.000256	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.62e-05	0.000255	CbGpPWpGaD
Norepinephrine—ADRA2B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.62e-05	0.000254	CbGpPWpGaD
Norepinephrine—ADRB2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.6e-05	0.000251	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.56e-05	0.000245	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.54e-05	0.000241	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.54e-05	0.000241	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.52e-05	0.000238	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.51e-05	0.000238	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.51e-05	0.000238	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.51e-05	0.000236	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.49e-05	0.000234	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.49e-05	0.000233	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.49e-05	0.000233	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.48e-05	0.000232	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.47e-05	0.000231	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.47e-05	0.000231	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.45e-05	0.000228	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.42e-05	0.000222	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.41e-05	0.000221	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.39e-05	0.000219	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.38e-05	0.000217	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.38e-05	0.000216	CbGpPWpGaD
Norepinephrine—DRD2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.37e-05	0.000216	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.36e-05	0.000214	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.35e-05	0.000212	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.34e-05	0.000211	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.32e-05	0.000208	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.28e-05	0.0002	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.27e-05	0.000199	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.25e-05	0.000196	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.25e-05	0.000196	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—ALB—acquired immunodeficiency syndrome	1.23e-05	0.000193	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.23e-05	0.000193	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.23e-05	0.000193	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.21e-05	0.000189	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.2e-05	0.000189	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—ALB—acquired immunodeficiency syndrome	1.2e-05	0.000188	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—ALB—acquired immunodeficiency syndrome	1.15e-05	0.00018	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.14e-05	0.000179	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.12e-05	0.000175	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—ALB—acquired immunodeficiency syndrome	9.73e-06	0.000153	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—IL2—acquired immunodeficiency syndrome	9.63e-06	0.000151	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	9.59e-06	0.00015	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	8.78e-06	0.000138	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	8.73e-06	0.000137	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	8.7e-06	0.000137	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	8.69e-06	0.000136	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	8.65e-06	0.000136	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	8.59e-06	0.000135	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	8.54e-06	0.000134	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	8.12e-06	0.000128	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	8.08e-06	0.000127	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	8e-06	0.000126	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.96e-06	0.000125	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.37e-06	0.000116	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.33e-06	0.000115	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.1e-06	0.000111	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.07e-06	0.000111	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.6e-06	0.000104	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.57e-06	0.000103	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.66e-06	8.89e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—ALB—acquired immunodeficiency syndrome	5.37e-06	8.43e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.16e-06	8.1e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.11e-06	8.02e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.05e-06	7.92e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.78e-06	7.5e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.7e-06	7.38e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.33e-06	6.8e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.17e-06	6.55e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.88e-06	6.09e-05	CbGpPWpGaD
